Budget impact of introducing tofacitinib to the public hospital formulary in Hong Kong, 2017-2021
Hong Kong medical journal = Xianggang yi xue za zhi, 2019-06, Vol.25 (3), p.201-208 [Peer Reviewed Journal]2019. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1024-2708 ;EISSN: 2226-8707 ;DOI: 10.12809/hkmj187673 ;PMID: 31178440
Full text available